Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Liver Diseases 2022

About Conference


We cordially welcome you to attend the 13th International Conference on Liver Diseases & Hepatology which is scheduled during November 14-15, 2022 at Amsterdam, Netherlands.

This year we came up with the refreshing theme Implementing the new research ideas to eradicate Liver Diseases”. The main objective of the conference is to bring together leading academicians, scientists, researchers, graduate students, (GastroenterologistsHepatologistsNephrologistsPathologistsVirologistsOncology) environmental specialist & pharmaceutical specialist and others from all over the world. 

Liver Diseases 2022 is a two days conference organized by Organizing Committee Members where it starts with a keynote session followed by an oral presentation and poster presentations and final ends with the certificate distribution.

Hepatology is the study of Liver, gall bladder, biliary tree and pancreas and its disorders. This is the best chance for all the doctors as well as scientific researchers and students to find out the new techniques in Hepatology and find out the different ways of treatments to be given to the patients affected with Hepatitis. So, don’t miss the opportunity and be a part of it as the new era begins.

With members from around the world focused on learning about Liver Diseases and Hepatology. This is your best opportunity to reach the largest assemblage of participants from the Hepatology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Liver Diseases and Hepatology, treatment and surgery involved are hallmarks of this conference.

Scope of the Conference

Liver Diseases conference 2022 provides a great platform to grow your connections by gathering eminent people like professors, Researchers, scientists, industrialists, Students and delegates to exchange new ideas and knowledge. This conference is mainly focusing on a wide range of topics and allows participants to discuss about the management of liver diseases and Hepatitis. Liver Diseases conference 2022 consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters and video presenters will be judged and awarded during the conference. We encourage a broad participation from all over the world, Conference Series Ltd main motive is to spread the knowledge and exchange the ideas to build a smart and infectious free world.

Targeted Audience

  • Gastroenterologists
  • Hepatologists
  • Pathologists
  • Gynecologists
  • Radiologists
  • Oncologists
  • Research scholars
  • Doctors and General Physicians
  • Biotechnology and Bioinformatics students
  • Deans and Professors of Medicine & Hepatology departments
  • Professors & Students from cancer research centres
  • R&D department in pharmacy
  • Clinical Development Physicians, Researchers & Scientists
  • Public Health Professional
  • Medical Equipment Manufacturers
  • Hospitals and Health Services
  • Medical & Health care Organizations & Associations
  • Pancreas and Liver research institutes
  • Nurse and nursing education institutions
  • Medical Colleges
  • Business Professionals
  • Distributors/Sales Representatives
  • Pharmaceutical Companies
  • Cancer research universities in Asia-pacific regions

Come put your hand together and join with us @Liver Diseases 2022

Sessions/Tracks

Track 1: Liver Diseases

The liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discolouration of the skin (jaundice).

Track 2: Inherited Liver Diseases

Inherited Liver Diseases are genetically transferred from ancestors to the parents, grandchildren. The most important and chronic hereditary liver diseases vary from person to the person. Now a day’s scientists are telling that liver cancer is also a hereditary disease. Important inherited disorders causing acute and chronic liver diseases include hemochromatosis, Wilson's disease, alpha 1-antiprotease and cystic fibrosis. Important inherited disorders causing acute and chronic liver disease include hemochromatosis, Wilson's disease, alpha 1-antiprotease (antitrypsin) deficiency, and cystic fibrosis. Alpha 1-antiprotease is due to deficiency of antitrypsin.

Track 3: Liver and Biliary

The liver is the largest gland in the body and conducts a myriad of vital metabolic and excretory functions. In addition, by virtue of its circulatory relationship to the absorptive surface of the gastrointestinal tract, the liver is the initial site where ingested nutrients, and other substances entering via the gastrointestinal tract, such as drugs and bacterial metabolites, are processed by the body. Thus, the liver is a gate-keeper that can process useful substances while detoxifying orally absorbed substances that are potentially harmful, such as toxic xenobiotics.

Track 4: Liver Cirrhosis

Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function which include Fluid accumulation in your abdomen (ascites), Confusion, drowsiness and slurred speech (hepatic encephalopathy), Testicular atrophy in men, Breast enlargement in men. Cirrhosis can also cause portal hypertension, Enlargement of the spleen (splenomegaly).

Track 5: Hepato-Radiology

Liver imaging is basically for precise diagnosing biliary tract issue and is imperative for identifying liver injuries or damage and patients with a suspected malignancy is important because the liver is the common site of metastatic spread and those who are at the risk of developing hepatocellular carcinoma.

Track 6: Liver Injury and Immune Responses

Hepatic irritation is a typical finding amid an assortment of liver sicknesses including drug-prompted liver poisonous quality. The provocative phenotype can be credited to the intrinsic safe reaction produced by Kupffer cells, monocytes, neutrophils, and lymphocytes. The versatile invulnerable framework is additionally affected by the intrinsic resistant reaction prompting liver harm.

Track 7: Liver Function

The liver is the body’s largest internal organ that sits on the right-hand side of the belly. It is an essential organ that has many functions in the body, including making proteins and blood clotting factors, manufacturing triglycerides and cholesterol, glycogen synthesis and bile production. The liver filters the blood coming from the digestive tract and detoxifies the chemicals and metabolizes the vitamins, proteins, fats, carbohydrates and drugs. The liver secretes the bile that ends up back in the intestine.

Track 8: Hepato-Nephrology and Pathology

Liver pathology is altered in HRS while kidney histology is normal. It is a trichrome stain (chicken wire appearance) cirrhosis of the liver, the most common cause of HRS. The diagnosis of hepatorenal syndrome is depends on laboratory tests of individuals susceptible conditions.

Hepato-renal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dialysis, can prevent advancement of the condition.

HRS can affect individuals with cirrhosis, severe alcoholic hepatitis, or liver failure, and usually occurs when liver function deteriorates rapidly because of a sudden insult such as an infection, bleeding in the gastrointestinal tract, or overuse of diuretic medications.

Track 9: Hepatitis and its Types

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types Hepatitis A (HAV), Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis D (HDV) and Hepatitis E (HEV). These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. Types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Track 10: Hepatitis, Liver Diseases and Pregnancy

Intense viral hepatitis is the most widely recognized reason for jaundice in pregnancy. The course of most popular contaminations isn't influenced by pregnancy. Jaundice is a trademark highlight of the liver malady. The clinical signs and side effects are unclear between the different types of viral hepatitis, subsequently, the differential determination requires serologic testing for an infection conclusion, and the finding is by a biochemical appraisal of liver capacity.

Track 11: Hepatitis: Screening and Testing Methods

The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, haemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

Track 12: Prevention and Treatment for Hepatitis

To diagnose hepatitis, first, your doctor will take your history to determine any risk factors you may have for infectious or non-infectious hepatitis. Liver function tests use blood samples to determine how efficiently your liver works.

High liver enzyme levels may indicate that your liver is stressed, damaged, or not functioning properly. An abdominal ultrasound uses ultrasound waves to create an image of the organs within your abdomen. It can reveal Liver tumours, Liver failure, Abnormalities of the gall bladder. Treatment options are determined by which type of hepatitis you have and whether the infection is acute or chronic.

Track 13: Liver Transplantation and surgery

Liver transplant is an operation that replaces a replaces a person’s diseased heart with a partial or a whole liver from a donor. A rare condition in new-born infants is Biliary atresia in which the common bile ducts, which carry bile out of liver and present between the liver and small intestine is absent or blocked. Bariatric surgery performed on people, who have obesity through a variety of procedures. Removing a tissue sample (biopsy) from the liver may help diagnose liver disease. Liver biopsy is done using a long needle inserted through the skin to extract a tissue sample and then analysed in a laboratory

  • Liver Biopsy
  • Bariatric surgery
  • Living donor transplantation
  • Graft rejection
  • Immunosuppressive management

Track 14: Stem cell treatment on Liver Diseases

Cell therapy is an emerging approach being tested in this setting. Hepatocytes are the principal cells of the liver parenchyma and are responsible for maintaining liver function. They can originate from three sources. In a normal liver, hepatocytes themselves can proliferate to restore the functional liver mass, a mechanism that could be compromised in cirrhosis. Second, the liver contains liver progenitor cells that can also proliferate and differentiate into hepatocytes.

Chronic liver diseases can lead to cirrhosis, characterised by fibrous septa dissecting the liver parenchyma, affecting both liver function (due to reduced functional mass) and normal intrahepatic venous pressure (due to increased stiffness). Antiviral treatment for hepatitis B or C virus infection, alcohol abstinence for alcohol-related liver disease, or weight loss strategies for metabolic non-alcoholic fatty liver disease, whereas other causes remain difficult to treat (like genetic disorders or autoimmune problems). Despite existing strategies, some patients still progress towards end-stage liver disease and its associated complications, including ascites, peritonitis, variceal bleeding, or hepatocellular carcinoma. No treatment is available to specifically target fibrosis and cirrhosis, and liver transplantation remains the only curative option.

  • Advanced Cell Therapy
  • Differentiation of Hepatocytes
  • Biochemistry in Liver Development                      
  • Transplantation of Cells

Track 15: Hepatology and Nutrition

Gastroenterology, Hepatology and Nutrition the team of pediatric gastroenterologists, hepatologists, dietitians, clinicians and nurses are dedicated to helping children with common or complex gastrointestinal, liver and nutritional problems. The goals of the Gastroenterology Division are to provide outstanding medical care to persons with diseases of the gastrointestinal tract and liver, to train gastroenterology and to perform cutting-edge biomedical research to improve our understanding of digestive diseases.

Track 16: Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective, and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Track 17: Hepatocellular Carcinoma and Transarterial Chemo-Embolization

Hepatocellular carcinoma (HCC) is the most widely recognized kind of essential liver growth in grown-ups and is the most well-known reason for death in individuals with cirrhosis. It happens in the setting of incessant liver aggravation and is most firmly connected to endless viral hepatitis contamination (hepatitis B or C) or introduction to poisons, for example, liquor or Aflatoxin. Certain ailments, for example, hemochromatosis and alpha 1-antitrypsin lack, particularly increment the danger of treating HCC. Similarly, as with any malignancy, the treatment and forecast of HCC differ contingent upon the specifics of tumour histology, measure, how far growth has spread, and in general wellbeing.

Track 18: Liver Biopsy

A liver biopsy is a procedssssssure in which a small needle is inserted into the liver to collect a tissue sample. This is performed as an office or outpatient procedure or during surgery. The tissue is then analyzed in a laboratory to help doctors diagnose a variety of diseases and disorders in the liver. In most instances, there are no complications in obtaining a liver biopsy. However, rarely internal bleeding may occur, as well as a leak of bile from the liver or gallbladder.

  • Percutaneous liver biopsy
  • Transvenous liver biopsy
  • Laparoscopic liver biopsy

Track 19: Clinical Trials on Hepatology

Liver resection is the surgical removal of all or a portion of the liver. It is also referred to as a hepatectomy, full or partial. Complete liver resection is performed in the setting of a transplant a diseased liver is removed from a deceased donor (cadaver).  A living donor may also provide a piece of liver tissue which is procured through a partial hepatectomy. The procedure may be performed through a traditional open procedure or using minimally invasive techniques.

Market Analysis

Description

Recent Research on Liver Diseases in Singapore:

A research team based at Singapore University as used an integrated data analysis to classify hepatocellular carcinoma, the most common type of liver cancer, into three distinct subgroups, which should aid targeted treatment 

Singapore– Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally. Previous studies showed that this disease, especially its predominant form hepatocellular carcinoma (HCC), exhibits substantial heterogeneity. However, efforts to categorize HCC more precisely have been limited by an inability to integrate data from various sources into a single classification system. 

A Tokyo Medical and Dental University (TMDU)-centered research group has made a major advance in this field by combining data on mutations, gene expression patterns, and immunological status to shed light on the variation among cases of HCC. The study, recently reported in the journal EBioMedicine, reveals that there are actually three distinct types of this disease, which should help in predicting the prognosis of individual patients and treating them more effectively.

Global Hepatology and Liver Diseases market (2018-2025)

The global Infectious Diseases and therapy on Liver  market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025.

The growth of the Liver Cancer therapy market is primarily attributed to the increase in the number of therapies launched in the market. The development of new drugs is thus expected to drive the growth of Liver diseases therapy mainly Liver Cancer market. For instance, in October 2015, the FDA approved the Onivyde drug by Merrimack Pharmaceuticals, Inc. as a part of treatment regimen for advanced cancer. Some common side effects associated with chemotherapy drugs include diarrhea and abdominal cramping, fatigue, loss of appetite, change in food taste and others. Cancer cells that are rapidly growing are killed by chemotherapy

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Clinical Gastroenterology Journal

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by